Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Payoneer Global Inc (PAYO) vs Tilray Brands Inc (TLRY) Price & Performance

Payoneer Global IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Payoneer Global Inc vs Tilray Brands Inc — how do they compare? Payoneer Global Inc trades at $7.13 (market cap $2.41B), while Tilray Brands Inc trades at $4.19 (market cap $524.07M). The key difference: Payoneer Global Inc is far larger — about 4.6× Tilray Brands Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.

PAYOTLRY
Market Cap
$2.41B$524.07M
Sector
TechnologyHealth
52-Week High
$7.42$21.00
52-Week Low
$4.27$4.23
Enterprise Value
$2.15B$621.22M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Payoneer Global Inc

Payoneer Global (PAYO) trades at $7.12, unchanged on the day, with a bullish technical signal driven by moving averages. The company reported Q1 2026 EPS of $0.06, beating expectations, but faces scrutiny over its proposed acquisition by Nuvei for $7.40 per share. Revenue grew to $821 million in 2025, though net income fell to $73 million. Analyst consensus is 60% buy with a $8.20 price target, suggesting moderate upside from current levels.

The outlook is mixed: the acquisition offers a near-term floor but may undervalue growth potential. Risks include integration challenges and earnings volatility. Upside depends on execution of expansion initiatives like the new India tech hub. Investors should weigh acquisition certainty against long-term standalone value.

Tilray Brands Inc

TLRY trades at $4.23, down 1.63% on the day, with a bearish technical signal and negative earnings trends. The company reported a net loss of $2.19 billion in 2025 despite revenue growth to $821.31 million, reflecting deep profitability challenges. Analysts show cautious sentiment with 65% hold ratings, while recent news highlights expansion in medical cannabis and beverage segments amid ongoing regulatory uncertainty.

The outlook remains challenged by persistent losses and high debt-to-asset ratio of 12.25, though low P/S and P/B ratios suggest undervaluation. Key risks include profitability execution and federal cannabis policy shifts, while potential catalysts lie in international expansion and cost management improvements.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Payoneer Global Inc

Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.

Read more on PAYO

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY